I. Glenn Cohen

Q: What Schools Are Affiliated With I. Glenn Cohen

I. Glenn Cohen is affiliated with the following schools: Harvard University, Brown University, Princeton University, University of Toronto

I. Glenn Cohen's AcademicInfluence.com Rankings

I. Glenn Cohen

Law

#494

World Rank

#674

Historical Rank

International Law

#249

World Rank

#331

Historical Rank

law Degrees

I. Glenn Cohen

Philosophy

#2940

World Rank

#4874

Historical Rank

Bioethics

#35

World Rank

#35

Historical Rank

philosophy Degrees

Download Badge

Law
Philosophy

Why Is I. Glenn Cohen Influential?

(Suggest an Edit or Addition)

According to Wikipedia, I. Glenn Cohen is a Professor of Law at Harvard Law School. He is also the director of Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. Cohen has written a number of articles, appearing in journals such as the New England Journal of Medicine; JAMA; Cell; Nature; the Harvard, Stanford, Southern California, Minnesota, Iowa, and Hastings Law Reviews; the Harvard Journal of Law and Negotiation; the Harvard Journal of Law and Technology; the Food and Drug Law Journal; the Journal of Law, Medicine and Ethics; and the Hastings Center Reports. He has given interviews and been cited by the New York Times, Politico, CNN, ABC News, MSNBC, The Boston Globe, Mother Jones, NPR, PBS, and AOL News.

(See a Problem?)

I. Glenn Cohen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Privacy in the age of medical big data (2019) (415)
Machine learning in medicine: Addressing ethical challenges (2018) (305)
Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations (2017) (285)
FDA regulation of mobile health technologies. (2014) (216)
The legal and ethical concerns that arise from using complex predictive analytics in health care. (2014) (187)
Potential Liability for Physicians Using Artificial Intelligence. (2019) (153)
HIPAA and Protecting Health Information in the 21st Century (2018) (101)
A Framework for Ethical Payment to Research Participants (2018) (93)
Potential Legal Liability for Withdrawing or Withholding Ventilators During COVID-19: Assessing the Risks and Identifying Needed Reforms. (2020) (91)
Ethical and legal implications of the risks of medical tourism for patients: a qualitative study of Canadian health and safety representatives’ perspectives (2012) (78)
Protecting Patients with Passports: Medical Tourism and the Patient Protective-Argument (2010) (75)
Digital Smartphone Tracking for COVID-19: Public Health and Civil Liberties in Tension. (2020) (73)
Regulatory, safety, and privacy concerns of home monitoring technologies during COVID-19 (2020) (71)
Transplant Tourism: The Ethics and Regulation of International Markets for Organs (2013) (62)
Big Data, Big Tech, and Protecting Patient Privacy. (2019) (62)
The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine (2018) (61)
The Price of Everything, the Value of Nothing: Reframing the Commodification Debate (2005) (59)
Beware explanations from AI in health care (2021) (57)
The need for a system view to regulate artificial intelligence/machine learning-based software as medical device (2020) (52)
Algorithms on regulatory lockdown in medicine (2019) (49)
Circumvention tourism. (2012) (48)
Consensus Statement on Electronic Health Predictive Analytics: A Guiding Framework to Address Challenges (2016) (44)
Universal Masking in the United States: The Role of Mandates, Health Education, and the CDC. (2020) (43)
Medical Tourism, Access to Health Care, and Global Justice (2011) (43)
Transatlantic lessons in regulation of mitochondrial replacement therapy (2015) (41)
Informed Consent and Medical Artificial Intelligence: What to Tell the Patient? (2020) (41)
Designing development programs for non-traditional antibacterial agents (2019) (40)
Patients with Passports: Medical Tourism, Law, and Ethics (2014) (39)
When clinical trials compete: prioritising study recruitment (2017) (37)
Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries (2019) (36)
Digital Health Passes in the Age of COVID-19: Are "Vaccine Passports" Lawful and Ethical? (2021) (34)
Legislation to Criminalize Gender-Affirming Medical Care for Transgender Youth. (2021) (32)
Medical Tourism: The View from Ten Thousand Feet (2010) (32)
A Fuller Picture of Organ Markets (2014) (32)
Future-proofing global health: Governance of priorities (2018) (31)
The FDA is prohibited from going germline (2016) (31)
Gore, Gibson, and Goldsmith: The Evolution of Internet Metaphors in Law and Commentary (2003) (31)
Disruptive reproductive technologies (2017) (30)
The Right Not to Be a Genetic Parent (2013) (30)
Identified versus statistical lives : an interdisciplinary perspective (2015) (29)
How to regulate medical tourism (and why it matters for bioethics). (2012) (29)
The need for a system view to regulate artificial intelligence/machine learning-based software as medical device. (2020) (28)
Building Capacity for a Global Genome Editing Observatory: Conceptual Challenges. (2018) (27)
Beyond Best Interests (2012) (27)
Big Data, Health Law, and Bioethics (2018) (25)
Human embryonic stem-cell research under siege--battle won but not the war. (2011) (24)
The European artificial intelligence strategy: implications and challenges for digital health. (2020) (24)
Ethical and legal issues of ingestible electronic sensors (2019) (23)
Ethical and Legal Aspects of Ambient Intelligence in Hospitals. (2020) (22)
The Globalization of Health Care: Legal and Ethical Issues (2013) (22)
Building Capacity for a Global Genome Editing Observatory: Institutional Design. (2018) (21)
Regulating Reproduction: The Problem with Best Interests (2011) (21)
Nudging Health: Health Law and Behavioral Economics (2016) (20)
Embryo Disposition Disputes: Controversies and Case Law. (2016) (20)
How NFTs could transform health information exchange. (2022) (19)
Effect of Patient and Therapist Factors on Suicide Risk Assessment (2015) (19)
What (if anything) is Wrong With Human Enhancement? What (if anything) is Right with It? (2014) (19)
Regulating the Organ Market: Normative Foundations for Market Regulation (2014) (19)
Trading-Off Reproductive Technology and Adoption: Does Subsidizing IVF Decrease Adoption Rates and Should it Matter? (2010) (18)
Is There a Duty to Share Healthcare Data (2018) (17)
Direct-to-consumer medical machine learning and artificial intelligence applications (2021) (17)
Going Germline: Mitochondrial Replacement as a Guide to Genome Editing (2016) (16)
Confronting Biospecimen Exceptionalism in Proposed Revisions to the Common Rule. (2016) (16)
Mitochondrial Replacement Therapy: Unmade in the USA. (2017) (16)
Sperm donor anonymity and compensation: an experiment with American sperm donors (2016) (16)
Psychedelic therapy: a roadmap for wider acceptance and utilization (2021) (16)
Preventing Mitochondrial Diseases: Embryo-Sparing Donor-Independent Options. (2018) (16)
Patient-Centered Outcomes Research: Stakeholder Perspectives and Ethical and Regulatory Oversight Issues. (2018) (15)
The Regulation of Mitochondrial Replacement Techniques Around the World. (2020) (15)
The Supreme Court, the Texas Abortion Law (SB8), and the Beginning of the End of Roe v Wade? (2021) (14)
Reconsideration of the lifetime ban on blood donation by men who have sex with men. (2014) (13)
Physicians, medical ethics, and execution by lethal injection. (2014) (13)
Oversight of Patient-Centered Outcomes Research: Recommendations From a Delphi Panel (2018) (13)
What Makes Artificial Intelligence Exceptional in Health Technology Assessment? (2021) (13)
Artificial Intelligence and Liability in Medicine: Balancing Safety and Innovation. (2021) (13)
Mitigating Racial Bias in Machine Learning (2022) (13)
The Football Players’ Health Study at Harvard University: Design and objectives (2019) (13)
Medical Crowdfunding for Unproven Medical Treatments: Should Gofundme Become a Gatekeeper? (2019) (13)
A Proposal to Address NFL Club Doctors’ Conflicts of Interest and to Promote Player Trust (2016) (12)
Are All Abortions Equal? Should There Be Exceptions to the Criminalization of Abortion for Rape and Incest? (2015) (12)
Made-to-order embryos for sale--a brave new world? (2013) (12)
Fetal Pain, Abortion, Viability, and the Constitution (2011) (12)
When religious freedom clashes with access to care. (2014) (12)
Heritable Human Genome Editing: The Public Engagement Imperative. (2020) (11)
Can the Government Ban Organ Sale? Recent Court Challenges and the Future of US Law on Selling Human Organs and Other Tissue (2012) (11)
The Interstate Medical Licensure Compact: Attending to the Underserved. (2021) (11)
Cops, Docs, and Code: A Dialogue between Big Data in Health Care and Predictive Policing (2018) (11)
Inbound medical tourism to Barbados: a qualitative examination of local lawyers’ prospective legal and regulatory concerns (2015) (11)
Artificial Wombs and Abortion Rights. (2017) (11)
When science and politics collide: Enhancing the FDA (2019) (10)
How does emerging patent case law in the US and Europe affect precision medicine? (2019) (10)
The looming threat of liability for accountable care organizations and what to do about it. (2013) (10)
How Much Can Potential Jurors Tell Us About Liability for Medical Artificial Intelligence? (2021) (10)
Hospital-based active shooter incidents: sanctuary under fire. (2015) (9)
Your Money or Your Patient's Life? Ransomware and Electronic Health Records (2017) (9)
Human Subjects Research Regulation: Perspectives on the Future (2014) (9)
In the wake of Guatemala: the case for voluntary compensation and remediation. (2012) (9)
Rethinking Sperm-Donor Anonymity: Of Changed Selves, Non-Identity, and One-Night Stands (2011) (9)
Ethical and Legal Implications of Remote Monitoring of Medical Devices. (2020) (9)
Preventing Mitochondrial DNA Diseases: One Step Forward, Two Steps Back. (2016) (9)
Circumvention Medical Tourism and Cutting Edge Medicine: The Case of Mitochondrial Replacement Therapy (2018) (9)
Making Residency Work Hour Rules Work (2013) (8)
Therapeutic orphans, pediatric victims? The Best Pharmaceuticals for Child Act and existing pediatric human subject protection. (2004) (8)
Clinical decision making regarding suicide risk: Effect of patient and clinician age (2016) (8)
In support of mitochondrial replacement therapy (2019) (8)
What Overturning Roe v Wade May Mean for Assisted Reproductive Technologies in the US. (2022) (8)
Mitchochondrial replacement therapy: the IOM report and its aftermath (2016) (8)
Heritable Genome Editing: Is a Moratorium Needed? (2019) (8)
Protecting and Promoting the Health of NFL Players: Legal and Ethical Analysis and Recommendations (2016) (8)
Evaluating NFL Player Health and Performance: Legal and Ethical Issues (2017) (8)
Heritable Human Genome Editing: The International Commission Report. (2020) (8)
Stem Cell-Derived Human Gametes: The Public Engagement Imperative. (2019) (7)
Navigating physicians' ethical and legal duties to patients seeking unproven interventions abroad. (2015) (7)
Comparing Health-Related Policies & Practices in Sports:: The NFL and Other Professional Leagues (2017) (7)
IRB Oversight of Patient-Centered Outcomes Research: A National Survey of IRB Chairpersons (2018) (7)
Medical Tourism, Medical Migration, and Global Justice: Implications for Biosecurity in a Globalized World (2017) (6)
How bans on germline editing deprive patients with mitochondrial disease (2019) (6)
Supreme Court Ruling on the Texas Abortion Law: Beginning to Unravel Roe v Wade. (2022) (6)
Negotiating Death: ADR and End of Life Decision-making (2004) (6)
Trading-Off Reproductive Technology and Adoption: Does Subsidizing in Vitro Fertilization Decrease Adoption Rates and Should it Matter? (2010) (6)
Regulation of Stem Cell Therapy Travel (2018) (6)
Effect of a legal prime on clinician’s assessment of suicide risk (2016) (6)
Legislation restricting gender-affirming care for transgender youth: Politics eclipse healthcare (2022) (6)
Overcoming obstacles to experiments in legal practice (2020) (6)
Patents on Psychedelics: The Next Legal Battlefront of Drug Development (2021) (6)
The Pandemic Preparedness Program: Reimagining Public Health. (2022) (5)
Editing the Genome of the Human Germline: May Cool Heads Prevail (2015) (5)
Organs Without Borders? Allocating Transplant Organs, Foreigners, and the Importance of the Nation State (?) (2014) (5)
The Ethics of Heritable Genome Editing: New Considerations in a Controversial Area. (2018) (5)
Legal and Ethical Issues in the Report Heritable Human Genome Editing. (2021) (5)
Reproduction reimagined. (2020) (5)
Disruptive Synergy: Melding of Human Genetics and Clinical Assisted Reproduction (2020) (5)
Of Modest Proposals and Non-Identity: A Comment on the Right to Know Your Genetic Parents (2013) (5)
Sharing Clinical Notes: Potential Medical-Legal Benefits and Risks. (2022) (5)
SARS-CoV-2 Laboratory-Developed Tests: Integrity Restored. (2022) (5)
The End of Roe v Wade and New Legal Frontiers on the Constitutional Right to Abortion. (2022) (5)
Life on an Emotional Roller Coaster: NFL Players and Their Family Members’ Perspectives on Player Mental Health (2018) (5)
Selling bone marrow--Flynn v. Holder. (2012) (4)
This Is Your Brain on Human Rights: Moral Enhancement and Human Rights (2015) (4)
Therapeutic Germline Editing: Sense and Sensibility. (2020) (4)
Nonexceptionalism, Research Risks, and Social Media: Response to Open Peer Commentaries on “Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations” (2017) (4)
Chapter 10: Medical Outlaws or Medical Refugees? An Examination of Circumvention Tourism (2012) (4)
Gene Editing Sperm and Eggs (not Embryos): Does it Make a Legal or Ethical Difference? (2020) (4)
Invited Perspective: How Much Can Potential Jurors Tell Us about Liability for Medical AI? (2020) (4)
The constitutionality of the ACA's Medicaid-expansion mandate. (2012) (4)
Mitochondrial replacement therapy: born in the USA: the untold story of a conceptual breakthrough (2017) (4)
Sperm and Egg Donor Anonymity: Legal and Ethical Issues (2015) (4)
Commentary on ‘Gestation, Equality and Freedom: Ectogenesis as a Political Perspective’ (2020) (4)
Preventing Mitochondrial Disease: A Path Forward. (2018) (4)
Truth in Advertising (2018) (3)
Acute Hospital Care at Home in Medicare-Will a Pandemic Policy Be Sustained? (2022) (3)
Deadly Legacy-The 510(k) Path to Medical Device Clearance. (2021) (3)
Medical tourism for services illegal in patients’ home country (2015) (3)
Medical Tourism and Global Justice (2013) (3)
Personhood and the Three Branches of Government. (2018) (3)
Mitochondrial disease: Replace or edit? (2021) (3)
The taxing power and the public's health. (2012) (3)
Law, Religion, and Health in the United States (2017) (3)
Skating the line between general wellness products and regulated devices: strategies and implications (2022) (3)
The Next Two Decades of Mifepristone at FDA: History as Destiny. (2022) (3)
Germ-Line Gene Editing and Congressional Reaction in Context: Learning From Almost 50 Years of Congressional Reactions to Biomedical Breakthroughs. (2017) (3)
Medical Assistance in Dying and 'Suicide Tourism' to Canada: Bill C-14 from a Comparative Perspective (2016) (3)
Streamlining Review by Accepting Equivalence (2014) (3)
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies (2015) (3)
Mounting Violence in Healthcare: Is It Time to Harden the Sanctuary? (2022) (2)
Religion and Reproductive Technology (2016) (2)
Response to Open Peer Commentaries on “The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine” (2018) (2)
Prohibiting Anonymous Sperm Donation and the Child Welfare Error (2011) (2)
“I’d feel like someone was watchin’ me… watching for a good reason”: perceptions of data privacy, access, and sharing in the context of real-time PrEP adherence monitoring among HIV-negative MSM with substance use (2022) (2)
Quality and Information (2014) (2)
The American Rescue Plan Act of 2021: A Historic if Transitory Expansion of the ACA. (2021) (2)
Who will oversee the ethical limits of human embryo research? (2022) (2)
Review of Paul Knoepfler, GMO Sapiens: The Life-Changing Science of Designer Babies (2016) (2)
Administrative developments: new human subject research guidelines for IRBs. (2000) (2)
The Right(s) to Procreate and Assisted Reproductive Technologies in the United States (2020) (2)
What would responsible remedial human germline editing look like? (2020) (2)
Germline editing: could ban encourage medical tourism? (2019) (2)
Ideology v. Beneficence (2017) (2)
From Medical Experimentation to Non-Medical Experimentation (2016) (2)
Plan B: access to emergency contraception in the legal and political cross hairs. (2013) (2)
American Journal of Law & Medicine and Harvard Law & Health Care Society (2000) (2)
S.H. and Others v. Austria and circumvention tourism (2012) (2)
Medical Tourism in the Tropics: New Regulation is Needed to Tackle Equity and Quality Concerns in Barbados (2015) (2)
Sherley v Sebelius and the future of stem cell research. (2012) (2)
Handle with Care: The WHO Report on Human Genome Editing. (2022) (2)
Emerging Ethical Considerations for the Use of Artificial Intelligence in Ophthalmology (2022) (2)
Enforcement of the Physician Payments Sunshine Act: Trust and Verify. (2021) (2)
The hospital-at-home presents novel liabilities for physicians, hospitals, caregivers, and patients (2022) (2)
Gestational Surrogacy Agreements: Enforcement and Breach (2016) (2)
Ethical considerations surrounding lethal injection--reply. (2014) (2)
Digital Health Passes in the Age of COVID-19: Are 'Vaccine Passports' Lawful and Ethical? (2021) (2)
Personhood Seeking New Life with Republican Control (2017) (1)
Industry-Sponsored Speaker Programs-End of the Line? (2021) (1)
Antiviral Therapeutics: Key to Curbing the COVID-19 Pandemic (2021) (1)
On Scarcity and the Value of Clinical Trials (2018) (1)
The Biden Administration's Proposal for an Advanced Research Projects Agency for Health. (2021) (1)
Losing Embryos, Finding Justice: Life, Liberty, and the Pursuit of Personhood (2018) (1)
Pressing regulatory challenges for psychedelic medicine (2023) (1)
RELIGION, LAW, AND PUBLIC HEALTH: INTRODUCTION (2017) (1)
Big Data, Health Law, and Bioethics: Introduction (Cambridge University Press, 2018) (2018) (1)
Identified versus Statistical Lives in US Civil Litigation (2015) (1)
Governing Human Germline Editing Through Patent Law. (2021) (1)
The Affordable Care Act Resurrected: Curtailing the Ranks of the Uninsured. (2021) (1)
Front Matter, Preface, and An Introduction to: Patients with Passports Medical Tourism Law and Ethics (2014) (1)
S.H. and others v. Austria and circumvention tourism. (2012) (1)
Complexifying Commodification, Consumption, ART, and Abortion (2015) (1)
Sperm and Egg Donor Anonymity (2017) (1)
The FDA Struggle to Withdraw Makena: Problems With the Accelerated Approval Process. (2022) (1)
Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries (2019) (1)
HIPAA in the Era of Data Sharing-Reply. (2020) (1)
When Potential Does Not Matter: What Developments in Cellular Biology Tell Us About the Concept of Legal Personhood (2013) (1)
Clinical trials and the right to remain silent. (2014) (1)
June Medical Services v Russo-the Future of Abortion Access in the US. (2020) (1)
Public Engagement, Notice-and-Comment Rulemaking, and the Common Rule. (2017) (1)
A Doctor’s Touch: What Big Data in Health Care Can Teach Us About Predictive Policing (2019) (1)
Private Rights and the Public Interest in Drug and Medical Device Litigation. (2020) (1)
Beyond Security Patches-Fundamental Incentive Problems in Health Care Cybersecurity. (2021) (1)
Selective Regrets: The “Dickey Amendments” 20 Years Later (2015) (1)
Heritable Genome Editing-Edited Eggs and Sperm to the Rescue? (2019) (1)
Fertility Fraud, Legal Firsts, and Medical Ethics. (2019) (1)
Influence, integrity, and the FDA: An ethical framework (2017) (1)
Fertility Fraud, Legal Firsts, and Medical Ethics (2019) (1)
An Overdue Executive Order: Reinstating the National Bioethics Commission. (2021) (1)
At-home Diagnostics and Diagnostic Excellence: Devices vs General Wellness Products. (2022) (1)
NFL Player Health: The Role of Club Doctors (2016) (1)
Moratoria and Innovation in the Reproductive Sciences: Of Pretext, Permanence, Transparency, and Timelimits (2018) (1)
Medical Tourism and Ending Life: Travel for Assisted Suicide and Abortion (2014) (1)
CRISPR immunity: a case study for justified somatic genetic modification? (2021) (1)
A Troubling Court Decision for Reproductive Rights: Legal Recognition of Fetal Standing to Sue. (2019) (1)
Workplace Violence in Healthcare: Protective Federal Legislation Must Not Be Delayed. (2023) (0)
"I-TO-WE" Relationship Coaching Announces Free Couples Workshop Series (2007) (0)
Medical Tourism for Services Legal in the Home and Destination Country (2016) (0)
Estrogen or Testosterone Increases Facial and Body Attractiveness in Hypogonadal Adolescents 13 (1998) (0)
Derecho y tecnologías reproductivas (2014) (0)
Comparing the American and European experiences with medical tourism: legal and ethical issues (2017) (0)
How bans on germline editing deprive patients with mitochondrial disease (2019) (0)
Unsettled Liability Issues for "Prediagnostic" Wearables and Health-Related Products. (2022) (0)
In support of mitochondrial replacement therapy (2019) (0)
Drug Importation from Canada: The Wrong Prescription. (2023) (0)
Towards Responsible Quantum Technology (2023) (0)
The Reply. (2023) (0)
Privacy in the age of medical big data (2019) (0)
Introduction to Part I (2020) (0)
Travel to Other States for Abortion after Dobbs (2022) (0)
Bifurcation instructed design of multistate machines (2023) (0)
Introduction (2020) (0)
Introduction to Part II (2020) (0)
Institutions as an ethical locus of research prioritisation (2017) (0)
The End of Anonymous Sperm Donation in Colorado: A Step Forward to a New Fertility Future in the US? (2022) (0)
Not Your Father's Religious Exemptions: The Contraceptive- Coverage Litigation and the Rights of Others (2017) (0)
Was the Medicaid Expansion Coercive (2014) (0)
Biotech Juggernaut: Hope, Hype, and Hidden Agendas of Entrepreneurial. By TinaStevens and StuartNewman. Chicago, IL. University of Chicago Press, 2019. 206 pp. $42.95 paperback (2020) (0)
Medical Tourism through Public Health Insurance: The EU Model and Beyond (2014) (0)
The FDA Initiative to Assure Racial and Ethnic Diversity in Clinical Trials (2023) (0)
What Should ChatGPT Mean for Bioethics? (2023) (0)
The Law and Ethics of Fetal Burial Requirements for Reproductive Health Care. (2019) (0)
Introduction to the Right to Procreate and Assisted Reproductive Technologies (2020) (0)
ACCOUNTING FOR PATIENTS’ RELIGIOUS BELIEFS: INTRODUCTION (2017) (0)
Web Appendix 2 for 'Trading-Off Reproductive Technology and Adoption: Does Subsidizing in Vitro Fertilization Decrease Adoption Rates and Should it Matter?': Cross-Sectional Re-Analysis (2010) (0)
THE IMPACT OF RELIGIOUS OBJECTIONS ON THE HEALTH AND HEALTH CARE OF OTHERS: INTRODUCTION (2017) (0)
Assisted Reproduction Post-Dobbs: The Prospect of Legislative Protection (2023) (0)
Transparency and the Doctor-Patient Relationship - Rethinking Conflict-of-Interest Disclosures. (2022) (0)
Towards responsible quantum technology, safeguarding, engaging and advancing Quantum R&D (2023) (0)
Reproductive Freedom and the 2012 Presidential Election (2012) (0)
Medical Tourism’s Effects on the Destination Country: An Empirical and Ethical Examination (2014) (0)
Stamping Out the Medicaid Coverage Gap: An ACA Imperative. (2022) (0)
Should the Administration for Strategic Preparedness and Response Lead the National Response to a Public Health Emergency? (2023) (0)
Trading-Off Reproductive Technology and Adoption: A Response to Appleton and Pollak (2012) (0)
PROFESSIONAL RESPONSIBILITIES, RELIGION, AND HEALTH CARE: INTRODUCTION (2017) (0)
What big data in health care can teach us about predictive policing (2021) (0)
Introduction and Front Matter, Transparency in Health and Health Care in the United States: Law and Ethics (2019) (0)
The Regulation of Reproduction and Best Interests Analysis (2019) (0)
Liability for Use of Artificial Intelligence in Medicine (2022) (0)
An Introduction to the Medical Tourism Industry (2014) (0)
A Response to The Flaw in Formalist Accounts of Circumvention Tourism (2022) (0)
Medical Tourism through Private Health Insurance (2014) (0)
The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional. (2023) (0)
Changing conception (2019) (0)
Criminalizing medical errors will undermine patient safety (2022) (0)
Taxonomic transfers in Tolumnia (Orchidaceae: Oncidiinae). (2009) (0)
LAW, RELIGION, AND HEALTH CARE INSTITUTIONS: INTRODUCTION (2017) (0)
A Response to Appleton and Pollak (2012) (0)
Regulating Reasons: Governmental Regulation of Private Deliberation in Reproductive Decision Making (2017) (0)
The Case for Remedial Germline Editing-The Long-term View. (2020) (0)
A Divisive Ruling on Devices - Genus Medical Technologies v. FDA. (2021) (0)
What would responsible remedial human germline editing look like? (2020) (0)
Putting the Insanity Defense on Trial: Understanding Criminality in the Context of Religion and Mental Illness (2017) (0)
Hospital-at-Home: Multistakeholder Considerations for Program Dissemination and Scale. (2022) (0)
Assessing-and Extending-California's Insulin Manufacturing Initiative. (2023) (0)
The Natural Person as the Limiting Principle for Conscience: Can a Corporation Have a Conscience If It Doesn't Have an Intellect and Will? (2017) (0)
The HHS Mandate Litigation and Religious Health Care Providers (2017) (0)
The Lumbering Crawl Toward Human Germline Editing (2018) (0)
Ethical and legal issues of ingestible electronic sensors (2019) (0)
Burying Best Interests of the Resulting Child: A Response to Professors Crawford, Alvaré, and Mutcherson (2012) (0)
Introduction: Law, Religion, and Health in the United States (2017) (0)
VERSION Algorithms on Regulatory Lockdown in Medicine (0)
Science Magazine (2008) (0)
A Response to Commentaries (2016) (0)
When Failure Is Not an Option: The Independent Panel Pandemic Report (2021) (0)
The Inflation Reduction Act: Recasting the Medicare Prescription Drug Plans. (2023) (0)
Should Alexa diagnose Alzheimer’s?: Legal and ethical issues with at-home consumer devices (2022) (0)
Pharmaceutical Companies, Human Rights, and the Alien Tort Statute (2021) (0)
Medical Tourism and the Creation of Life: A Study of Fertility Tourism (2014) (0)
Ethics-by-design: efficient, fair and inclusive resource allocation using machine learning (2022) (0)
The PREVENT Pandemics Act: A National Road Map (2022) (0)
My Body, My Bank (2015) (0)
When Is a Change Significant? The Update Problem of Apps in Medical and Behavioral Research. (2022) (0)
A Legislative Blueprint for the Next Pandemic. (2020) (0)
Germline editing: could ban encourage medical tourism? (2019) (0)
On Repugnance, Distribution, and the Global Kidney Exchange (2018) (0)
Make it Work!: Breyer on Patents in the Life Sciences (2014) (0)
Regulation of Stem Cell Therapy Travel (2018) (0)
Mission Integrity Matters: Balancing Catholic Health Care Values and Public Mandates (2017) (0)
Religious Liberty, Health Care, and the Culture Wars (2017) (0)
Introduction to Part VI (2019) (0)
Regulating Bodies Across Borders: Medical Tourism for Services Legal in the Home and Destination Country: Legal and Ethical Issues (2015) (0)
Organ donor intervention trials and risk to bystanders: An ethical analysis (2019) (0)
Every pill you take (2018) (0)
The Enduring Allure of Person-Affecting Arguments for Reproductive Technologies (2022) (0)
When Religion Pollutes: How Should Law Respond When Religious Practice Threatens Public Health? (2017) (0)
A Corporation's Exercise of Religion: A Practitioner's Experience (2017) (0)
Traveling Across States for Prohibited Treatments: Medical Aid in Dying and Looming Battles Over Abortion (2022) (0)
Failing Grade: The Pandemic Legacy of HHS (2022) (0)
The Relationship between Bioethics and U.S. Health Law (2017) (0)
Medical Tourism for Experimental Therapies: An In-Depth Exploration of Stem Cell Therapy Tourism (2014) (0)
Appendix A: Comparison to the Insurance Mandate Categorizations of Other Studies (2010) (0)
On the Human Right to Health: Statistical Lives, Contingent Persons, and Other Difficult Questions (2018) (0)
Nudging the FDA (2014) (0)
The CMS Vaccine Mandate at the Supreme Court: A Hippocratic Imperative (2022) (0)
Honoring the public trust: curbing the bane of physician sexual misconduct (2022) (0)
A CASE STUDY – RELIGIOUS BELIEFS AND THE HEALTH OF THE LGBT COMMUNITY: INTRODUCTION (2017) (0)
The Case for Remedial Germline Editing-The Long-term View. (2020) (0)
Persistent Inpatient Harm: the Unremitting Challenge of Patient Safety (2022) (0)
Alliance for Hippocratic Medicine v. FDA - Dobbs's Collateral Consequences for Pharmaceutical Regulation. (2023) (0)
EMTALA After Dobbs: Emergency Reproductive Health Care in the Balance (2023) (0)
Accommodating Miracles: Medical Futility and Religious Free Exercise (2017) (0)
Expanding the Blood Pool: The Limitations of the FDA's Current MSM Blood Deferral. (2022) (0)
Statistical versus Identified Persons (2015) (0)
IntheWakeofGuatemala:TheCaseforVoluntary CompensationandRemediation (2012) (0)
Capping Prescription Drug Costs: State Initiatives to the Rescue? (2022) (0)
RELIGION AND REPRODUCTIVE HEALTH CARE: INTRODUCTION (2017) (0)
More than meets the IRB: On human subjects research and regulation: perspectives on the future (2015) (0)
Transparency in Health and Health Care (2019) (0)
Recent Case - Supreme Court of New Jersey Holds that Preembryo Disposition Agreements are Not Binding When One Party Later Objects - J.B. V. M.B. (2003) (0)
The Nursing Home Crisis: Prognosis Guarded. (2022) (0)
Introduction (2019) (0)
LAW, RELIGION, AND HEALTH INSURANCE: INTRODUCTION (2017) (0)
From Smith to Hobby Lobby : The Transformation of the Religious Freedom Restoration Act (2017) (0)
And Then There Were Three: The Decimation of the Affordable Care Act (ACA) CO-OPs (2022) (0)
Developing Recommendations for Oversight of Patient-Centered Outcomes Research—The PCOROS Study (2020) (0)
Letter to the Editor (2011) (0)
Preventing Female Genital Mutilation in the United States: The Legal Threat to Effective Action. (2020) (0)
The Legality of Biometric Screening of Professional Athletes (2017) (0)
Well, What About the Children? Best Interests Reasoning, the New Eugenics, and the Regulation of Reproduction (2010) (0)
Race, Religion, and Masculinity: The HIV Double Bind (2017) (0)
Introduction to Nudging Health: Health Law and Behavioral Economics (2016) (0)
Assisted Same-Sex Reproduction: The Promise of Haploid Stem Cells? (2020) (0)
Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply. (2022) (0)

This paper list is powered by the following services:

Other Resources About I. Glenn Cohen

en.wikipedia.org

What Schools Are Affiliated With I. Glenn Cohen?

I. Glenn Cohen is affiliated with the following schools:

I. Glenn Cohen's Academic­Influence.com Rankings

Why Is I. Glenn Cohen Influential?

I. Glenn Cohen's Published Works

Published Works

Other Resources About I. Glenn Cohen

What Schools Are Affiliated With I. Glenn Cohen?

I. Glenn Cohen's AcademicInfluence.com Rankings